Spotlight on brigatinib and its potential in the treatment of patients with metastatic ALK-positive non-small cell lung cancer who are resistant or intolerant to crizotinib

por Jain, Rohit K, Chen, Hongbin
Publicado 2017

Clinical Development of PARP Inhibitors in Treating Metastatic Castration-Resistant Prostate Cancer

por Adashek, Jacob J., Jain, Rohit K., Zhang, Jingsong
Publicado 2019

Emerging Treatment Options for the Treatment of Metastatic Urothelial Cancer: Therapeutic Potential of Enfortumab Vedotin

por Jain, Rohit K, Skelton, William Paul, Zhang, Jingsong
Publicado 2020

Case Report: Two Cases of Chemotherapy Refractory Metastatic Penile Squamous Cell Carcinoma With Extreme Durable Response to Pembrolizumab

por Chahoud, Jad, Skelton, William Paul, Spiess, Philippe E., Walko, Christine, Dhillon, Jasreman, Gage, Kenneth L., Johnstone, Peter A. S., Jain, Rohit K.
Publicado 2020

Case Report: Immune Checkpoint Inhibitor-Induced Exuberant Tumor Inflammation With Accelerated Clinical Deterioration in Metastatic Renal Cell Carcinoma

por Gopalakrishnan, Dharmesh, Jain, Rohit K., Herbst, Laurie, Sikorski, Marcus, Mandava, Silpa, Azabdaftari, Gissou, Xu, Bo, LeVea, Charles, Robillard, Kevin, Ernstoff, Marc S., George, Saby
Publicado 2021

The 12-CK Score: Global Measurement of Tertiary Lymphoid Structures

por Li, Roger, Berglund, Anders, Zemp, Logan, Dhillon, Jasreman, Putney, Ryan, Kim, Youngchul, Jain, Rohit K., Grass, G. Daniel, Conejo-Garcia, José, Mulé, James J.
Publicado 2021

Complete response to anti-PD-L1 antibody in a metastatic bladder cancer associated with novel MSH4 mutation and microsatellite instability

por Yang, Yuanquan, Jain, Rohit K, Glenn, Sean T, Xu, Bo, Singh, Prashant K, Wei, Lei, Hu, Qiang, Long, Mark, Hutson, Nicholas, Wang, Jianming, Battaglia, Sebastiano, George, Saby
Publicado 2020

FGFR2/3 genomic alterations and response to Enfortumab Vedotin in metastatic urothelial carcinoma

por Adib, Elio, El‐Zarif, Talal, Jain, Rohit K., Skelton, William P., Freeman, Dory, Curran, Catherine, Akl, Elie W., Nassar, Amin H., Ravi, Praful, Mantia, Charlene, Kwiatkowski, David J., Choueiri, Toni K., Sonpavde, Guru P.
Publicado 2021

Real-World Survival Outcomes Associated With First-Line Immunotherapy, Targeted Therapy, and Combination Therapy for Metastatic Clear Cell Renal Cell Carcinoma

por Chakiryan, Nicholas H., Jiang, Da David, Gillis, Kyle A., Green, Elizabeth, Hajiran, Ali, Hugar, Lee, Zemp, Logan, Zhang, Jingsong, Jain, Rohit K., Chahoud, Jad, Spiess, Philippe E., Sexton, Wade, Gilbert, Scott M., Manley, Brandon J.
Publicado 2021

TROPHY-U-01: A Phase II Open-Label Study of Sacituzumab Govitecan in Patients With Metastatic Urothelial Carcinoma Progressing After Platinum-Based Chemotherapy and Checkpoint Inhi...

por Tagawa, Scott T., Balar, Arjun V., Petrylak, Daniel P., Kalebasty, Arash Rezazadeh, Loriot, Yohann, Fléchon, Aude, Jain, Rohit K., Agarwal, Neeraj, Bupathi, Manojkumar, Barthelemy, Philippe, Beuzeboc, Philippe, Palmbos, Phillip, Kyriakopoulos, Christos E., Pouessel, Damien, Sternberg, Cora N., Hong, Quan, Goswami, Trishna, Itri, Loretta M., Grivas, Petros
Publicado 2021

Survival Outcomes Associated With Cytoreductive Nephrectomy in Patients With Metastatic Clear Cell Renal Cell Carcinoma

por Chakiryan, Nicholas H., Gore, L. Robert, Reich, Richard R., Dunn, Rodney L., Jiang, Da David, Gillis, Kyle A., Green, Elizabeth, Hajiran, Ali, Hugar, Lee, Zemp, Logan, Zhang, Jingsong, Jain, Rohit K., Chahoud, Jad, Spiess, Philippe E., Manley, Brandon J., Sexton, Wade J., Hollenbeck, Brent K., Gilbert, Scott M.
Publicado 2022